Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Samsung Medical Center

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Subsidiary

Established: 1994-01-01

Employees: 501

Market Cap: -

Website: http://www.samsunghospital.com

Clinical Trials

Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer

Phase 2

Conditions: Nasopharyngeal Cancer

Interventions: Drug: Docetaxel, Cisplatin

First Posted Date: 2011-03-10

Last Posted Date: 2011-03-10

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 51

Registration Number: NCT01312311

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)

Phase 2

Completed

Conditions: Hypopharyngeal Cancer

Interventions: Drug: No treatment before definitive CCRT
Drug: neoadjuvant docetaxel/cisplatin/fluorouracil

First Posted Date: 2011-03-10

Last Posted Date: 2019-12-09

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 40

Registration Number: NCT01312350

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer

Phase 2

Completed

Conditions: Locally Advanced Stage III or IV Thymic Cancer

Interventions: Drug: neoadjuvant docetaxel/cisplatin

First Posted Date: 2011-03-10

Last Posted Date: 2016-04-20

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 27

Registration Number: NCT01312324

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab

Completed

Conditions: Patients With Diffuse Large B-cell Lymphoma or Follicular Lymphoma
Patients Treated With Rituximab-CHOP or Rituximab-CVP

First Posted Date: 2011-03-09

Last Posted Date: 2017-10-27

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 600

Registration Number: NCT01311232

Locations: 🇨🇳
Queen Mary Hospital, Hing Kong, China
🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
🇲🇾
Hospital Kuala Lumpur, Kuala Lumpur, Malaysia

and more 1 locations

Comparison of Tianeptine Versus Escitalopram Patients Major Depressive Disorder

Phase 4

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: Tianeptine
Drug: Escitalopram

First Posted Date: 2011-03-07

Last Posted Date: 2013-01-25

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 164

Registration Number: NCT01309776

Locations: 🇰🇷
Inje University Paik Hospital, Goyang, Korea, Republic of
🇰🇷
Inje University Seoul Paik Hospital, Seoul, Korea, Republic of
🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

and more 3 locations

Efficacy of Ecabet Sodium and Proton Pump Inhibitor Combination Therapy in the Treatment of Iatrogenic Ulcer After Endoscopic Submucosal Dissection

Phase 4

Conditions: Delayed Bleeding,
Quality of Ulcer
Healing Ulcer

Interventions: Drug: Ecabet

First Posted Date: 2011-03-03

Last Posted Date: 2011-03-03

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 90

Registration Number: NCT01308177

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Chemotherapy With or Without Radiosurgery for Asymptomatic Oligo Brain Metastasis

Phase 3

Conditions: Nonsmall Cell Lung Cancer

Interventions: Radiation: Radiosurgery
Radiation: Observation

First Posted Date: 2011-02-23

Last Posted Date: 2011-02-23

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 176

Registration Number: NCT01301560

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH)

Phase 4

Completed

Conditions: Benign Prostatic Hyperplasia

Interventions: Drug: alpha blocker monotherapy
Drug: 5 alpha reductase inhibitor monotherapy
Drug: combination therapy

First Posted Date: 2011-02-23

Last Posted Date: 2019-12-02

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 308

Registration Number: NCT01301599

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

HER2 Circulating Tumor Cells in Gastric Cancer

Completed

Conditions: Gastric Cancer

First Posted Date: 2011-02-18

Last Posted Date: 2018-01-17

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 135

Registration Number: NCT01299688

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Evaluation of Antifungal Prophylaxis on Graft-versus-host Disease (GVHD) Patients

Phase 4

Terminated

Conditions: Graft vs Host Disease

Interventions: Drug: Itraconazole

First Posted Date: 2011-01-25

Last Posted Date: 2011-01-25

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 36

Registration Number: NCT01282879

Locations: 🇰🇷
Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do, Korea, Republic of
🇰🇷
Soonchunhyang University Bucheon Hospital, Bucheon, Kyounggi-do, Korea, Republic of
🇰🇷
Gachon University Gil Hospital, Incheon, Korea, Republic of

and more 6 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy